儿科研究中临床前系统审查和元分析的价值
Olga Romantsik1, Matthias Bank2, Julia M L Menon3
1Department of Clinical Sciences Lund, Division of Pediatrics, Lund University, Skåne University Hospital, Lund, 21185, Sweden. olga.romantsik@med.lu.se.
Pediatric research
|April 13, 2024
概括
临床前系统性审查 (SRs) 对于评估研究和指导临床试验至关重要. 严格的方法和特别注意儿科考虑是可靠的证据综合的必要条件.
科学领域:
- 临床前研究和系统审查.
- 在生物医学科学中的证据综合.
背景情况:
- 临床前研究中的系统性审查 (SRs) 镜像临床SRs,识别知识差距和方法缺陷.
- 临床前SR的目的是评估临床试验准备的治疗策略,并证明新的研究是合理的.
研究的目的:
- 强调在临床前系统审查中严格的方法的重要性.
- 突出针对临床前研究的儿科系统性审查的具体考虑因素.
主要方法:
- 遵守SRs的既定方法标准,包括协议注册.
- 应用指导方针来评估偏见风险,研究质量和证据确定性.
- 在SRs中考虑儿童群体的年龄适应性和生理变化.
主要成果:
- 经过良好进行的临床前SRs提供可靠的证据综合.
- 结果可以指导未来临床前和临床研究的设计.
结论:
- 严格的设计,进行和报告对于临床前研究和SRs至关重要.
- 儿科SR需要特别注意特定年龄的特征,以准确解释.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
01:12Hazard Ratio
116
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
116